Biologics & Biosimilars By Signicent
Innovations in Biologics & Biosimilars

With the major advancements in the field of technology, one cannot deny the fact that companies are adopting new technological approaches for making their products/techniques better with time.

Read More
Nutraceutical By Signicent
Nutraceuticals: Why you should consider adding them to your diet?

Nutraceutical products are non-specific biological therapies that promote general well-being, control symptoms, and prevent malignant processes. They are rich in natural components that are beneficial in preventive medicine or disease treatment.

Read More
Glyoconjigate Vaccine Report By Signicent
Glycoconjugate Vaccines- An effective form of Immunization

Sweet vaccines are glycoconjugate-based vaccines that are composed of synthetic glycoconjugates along with an inhibitor. Both glycoconjugate and inhibitor play a vital role in vaccines.

Read More
Liposomal Drug Delivery System by Signicent
Liposomal Drug Delivery Systems: Why Nanomedicine Seems Promising?

The objective of the report is to explore the domain of liposomal drug delivery systems. The report will include the technology research, market research and competitive aspect of liposomal drug delivery systems in various industries.

Read More
Antimicrobial Resistance By Signicent
Antimicrobial Resistance Report: Can Innovative Therapies Tackle Multidrug Resistant Pathogen Crisis?

Antimicrobial resistance report discusses about multidrug-resistant pathogens & therapies to combat antimicrobial resistance such as phage therapy, probiotics, antimicrobial peptides, novel antibodies, CRISPR/ Cas9 etc.

Read More
Quasi Drugs By Signicent
Quasi-Drugs Report: The Regulated Cosmeceuticals with Growing Market

Quasi Drugs can be classified into 3 categories. Group 1 has items used for sanitary purposes such as sanitary pads, tampons, and menstrual pads. The textile used for manufacturing masks such as dust and surgical masks.

Read More